The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis (2021) Cirac A, Tsaktanis T, Beyer T, Linnerbauer M, Andlauer T, Grummel V, Nirschl L, et al. Journal article B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis (2021) Tacke S, Braune S, Rovituso DM, Ziemssen T, Lehmann P, Dikow H, Bergmann A, Kürten S Journal article Aryl Hydrocarbon Receptor Activation in Astrocytes by Laquinimod Ameliorates Autoimmune Inflammation in the CNS (2021) Rothhammer V, Kenison JE, Li Z, Tjon E, Takenaka MC, Chao CC, Alves de Lima K, et al. Journal article Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS (2021) Tsaktanis T, Beyer T, Nirschl L, Linnerbauer M, Grummel V, Bussas M, Tjon E, et al. Journal article CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis. (2021) Duerr M, Nissen G, Suehs KW, Schwenkenbecher P, Geis C, Ringelstein M, Hartung HP, et al. Journal article Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis. (2021) Tietz AK, Angstwurm K, Baumgartner T, Doppler K, Eisenhut K, Elisak M, Franke A, et al. Journal article Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry. (2021) Thaler FS, Zimmermann L, Kammermeier S, Strippel C, Ringelstein M, Kraft A, Suhs KW, et al. Journal article Genetic determinants of the humoral immune response in MS (2020) Gasperi C, Andlauer TFM, Keating A, Knier B, Klein A, Pernpeintner V, Lichtner P, et al. Journal article Serum antibodies to phosphatidylcholine in MS (2020) Cruz Sadaba M, Rothhammer V, Munoz U, Sebal C, Escudero E, Kivisakk P, Garcia Sanchez MI, et al. Journal article IsAPOE epsilon 4 associated with cognitive performance in early MS? (2020) Engel S, Graetz C, Salmen A, Muthuraman M, Toenges G, Ambrosius B, Bayas A, et al. Journal article